Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Abbott Laboratories (NYSE:ABT) Upgraded to "Buy" at Rothschild & Co Redburn

Summary by MarketBeat
Rothschild & Co Redburn upgraded shares of Abbott Laboratories from a "neutral" rating to a "buy" rating and lifted their target price for the stock from $119.00 to $127.00 in a research report on Friday.

1 Articles

MarketBeatMarketBeat
Center

Abbott Laboratories (NYSE:ABT) Upgraded to "Buy" at Rothschild & Co Redburn

Rothschild & Co Redburn upgraded shares of Abbott Laboratories from a "neutral" rating to a "buy" rating and lifted their target price for the stock from $119.00 to $127.00 in a research report on Friday.

·Sioux Falls, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

MarketBeat broke the news in Sioux Falls, United States on Friday, October 2, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Abbott Laboratories icon

Abbott Laboratories

Stock Markets icon

Stock Markets

Illinois icon

Illinois

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal